Figure S18 from HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity

Fig. S18. Correlation of the effect of HDAC6 inhibitors on proteasome activity with the effect on MHC-I antigen presentation. a.) Effect of tubastatin-A on proteasome activity correlated with the effect on pan HLA-ABC antigen presentation. b.) Effect of ACY-738 on proteasome activity correlation with the effect on pan HLA-ABC antigen presentation c.) Effect of ACY-1215 on proteasome activity correlated with the effect on pan HLA-ABC antigen presentation.